Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Receivables (2016 - 2025)

CorMedix (CRMD) has disclosed Receivables for 12 consecutive years, with $171.2 million as the latest value for Q4 2025.

  • Quarterly Receivables rose 231.5% to $171.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $171.2 million through Dec 2025, up 231.5% year-over-year, with the annual reading at $171.2 million for FY2025, 231.5% up from the prior year.
  • Receivables hit $171.2 million in Q4 2025 for CorMedix, up from $162.6 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $171.2 million in Q4 2025 to a low of $2975.0 in Q1 2022.
  • Historically, Receivables has averaged $36.8 million across 4 years, with a median of $706337.0 in 2024.
  • Biggest five-year swings in Receivables: soared 1251.44% in 2021 and later plummeted 93.18% in 2022.
  • Year by year, Receivables stood at $45368.0 in 2021, then crashed by 93.44% to $2975.0 in 2022, then soared by 1736168.91% to $51.7 million in 2024, then skyrocketed by 231.5% to $171.2 million in 2025.
  • Business Quant data shows Receivables for CRMD at $171.2 million in Q4 2025, $162.6 million in Q3 2025, and $100000.0 in Q2 2025.